Coherus Oncology, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Coherus Oncology, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $58.00K.
- Coherus Oncology, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $57.00K.
- Coherus Oncology, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $5.00K.
- Coherus Oncology, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $291.00K, a 182.52% increase year-over-year.
- Coherus Oncology, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $27.00K, a 90.72% decline from fiscal 2024.
- Coherus Oncology, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $291.00K.
- Coherus Oncology, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $691.00K, a 93.36% decline from fiscal 2021.
- Coherus Oncology, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $10.41M, a 38.98% decline from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $58.00K 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $57.00K 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $27.00K 10-K · filed 2026-03-09 | |
| 2025-09-30 | $5.00K 10-Q · filed 2025-11-06 | |
| 2024-12-31 | $291.00K 10-K · filed 2026-03-09 | |
| 2024-03-31 | $291.00K 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $694.00K 8-K · filed 2025-11-13 | |
| 2023-09-30 | $53.00K 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $14.00K 10-Q · filed 2024-11-06 | |
| 2023-03-31 | $103.00K 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $691.00K 10-K · filed 2025-03-17 | |
| 2022-09-30 | $79.00K 10-Q · filed 2023-11-06 | |
| 2022-06-30 | $8.00K 10-Q · filed 2023-11-06 | |
| 2022-03-31 | $544.00K 10-Q · filed 2023-11-06 | |
| 2021-12-31 | $10.41M 10-K · filed 2024-03-15 | |
| 2021-09-30 | $1.29M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $4.01M 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $4.43M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $17.06M 10-K · filed 2023-03-06 | |
| 2020-09-30 | $4.96M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $3.31M 10-Q · filed 2021-11-08 | |
| 2020-03-31 | $4.44M 10-Q · filed 2021-11-08 | |
| 2019-12-31 | $5.93M 10-K · filed 2022-02-23 | |
| 2019-09-30 | $3.71M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $674.00K 10-Q · filed 2019-11-08 | |
| 2019-03-31 | $825.00K 10-Q · filed 2019-11-08 | |
| 2018-12-31 | $2.15M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $1.40M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $284.00K 10-Q · filed 2019-11-08 | |
| 2018-03-31 | $225.00K 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $482.00K 10-K · filed 2020-02-27 | |
| 2016-12-31 | $3.31M 10-K · filed 2019-02-28 | |
| 2015-12-31 | $1.43M 10-K · filed 2018-03-08 | |
| 2014-12-31 | $55.00K 10-K · filed 2017-03-14 | |
| 2013-12-31 | $6.00K 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |